1. Home
  2. NEO vs DEI Comparison

NEO vs DEI Comparison

Compare NEO & DEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$13.05

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Douglas Emmett Inc.

DEI

Douglas Emmett Inc.

HOLD

Current Price

$11.19

Market Cap

1.9B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEO
DEI
Founded
2001
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.9B
IPO Year
1999
2006

Fundamental Metrics

Financial Performance
Metric
NEO
DEI
Price
$13.05
$11.19
Analyst Decision
Buy
Hold
Analyst Count
9
8
Target Price
$11.38
$15.29
AVG Volume (30 Days)
1.8M
2.1M
Earning Date
02-17-2026
02-10-2026
Dividend Yield
N/A
6.89%
EPS Growth
N/A
N/A
EPS
N/A
0.12
Revenue
$709,162,000.00
$1,000,336,000.00
Revenue This Year
$10.87
$2.92
Revenue Next Year
$9.84
$1.57
P/E Ratio
N/A
$88.57
Revenue Growth
10.10
3.61
52 Week Low
$4.72
$10.79
52 Week High
$16.18
$18.61

Technical Indicators

Market Signals
Indicator
NEO
DEI
Relative Strength Index (RSI) 62.37 43.79
Support Level $11.93 $10.97
Resistance Level $13.74 $11.68
Average True Range (ATR) 0.59 0.27
MACD 0.03 0.04
Stochastic Oscillator 69.46 42.55

Price Performance

Historical Comparison
NEO
DEI

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About DEI Douglas Emmett Inc.

Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. It is an owner and operator of office and multifamily properties located in coastal submarkets in Los Angeles and Honolulu. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments, the office segment and the multifamily segment.

Share on Social Networks: